Healthcare ETFs: Balancing broad exposure and sector-specific returns

What happened: Healthcare ETFs are under scrutiny for balancing broad exposure and sector-specific returns. The iShares Global Healthcare ETF (IXJ) offers lower costs and higher dividends, while the Simplify Health Care ETF (PINK) delivers stronger returns and donates profits to breast cancer research. Meanwhile, the First Trust NYSE Arca Biotechnology Index Fund (FBT) focuses exclusively on biotech, charging higher fees but offering potential for higher returns. Invesco Pharmaceuticals ETF (PJP) has outperformed the broader iShares U.S. Healthcare ETF (IYH) in the past year.

Market impact: Investors face trade-offs between cost, returns, and sector focus. Broader ETFs like IXJ and IYH provide diversification, while sector-specific ETFs like PINK and FBT offer higher potential returns but with increased risk. PINK's charitable component also appeals to socially conscious investors.

What to watch next: Upcoming catalysts include earnings reports from key healthcare companies held in these ETFs, such as Pfizer (PFE) and Amgen (AMGN) in Q2 2023. Additionally, regulatory decisions on drug approvals and pricing could impact biotech-focused ETFs like FBT. Lastly, monitor the performance of PINK as it approaches its one-year anniversary in May 2023 to assess the sustainability of its strong returns.